EurekAlert!, a service of AAAS
Home About us
Advanced Search
4-Jul-2015 11:25
US Eastern Time

Username:

Password:

Register

Forgot Password?

Press Releases

Breaking News

Science Business

Grants, Awards, Books

Meetings

Multimedia

Science Agencies
on EurekAlert!

US Department of Energy

US National Institutes of Health

US National Science Foundation

Calendar

Submit a Calendar Item

Subscribe/Sponsor

Links & Resources

Portals

RSS Feeds

Accessibility Option On

Options

Portal Home

Glossary

Background Articles

Research Papers

Meetings

Links & Resources

Bioinformatics

News Releases

Key: Meeting M      Journal J      Funder F

Showing releases 101-125 out of 793.

<< < 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 > >>

Public Release: 20-Apr-2015
PLOS Computational Biology
New tactic targets brain tumors
Patients who are obese, diabetic or both have the highest incidence of brain tumors, and they offer a clue that insulin is a factor for some glioblastoma patients. But a new Rice University study suggests drugs tested on such tumors targeted the wrong molecules.
National Science Foundation

Contact: David Ruth
david@rice.edu
713-348-6327
Rice University

Public Release: 20-Apr-2015
Conference on Human Factors in Computing Systems (CHI 2015)
Technology can transfer human emotions to your palm through air, say scientists
Human emotion can be transferred by technology that stimulates different parts of the hand without making physical contact with your body, a University of Sussex-led study has shown.
European Research Council

Contact: James Hakner
press@sussex.ac.uk
44-127-367-8888
University of Sussex

Public Release: 18-Apr-2015
American Association for Cancer Research Annual Meeting 2015
Study reveals a cause of poorer outcomes for African-American patients with breast cancer
Poorer outcomes for African-American women with estrogen-receptor positive breast cancer, compared with European-American patients, appears to be due, in part, to a strong survival mechanism within the cancer cells, according to a study.
Nina Hyde Center for Breast Cancer Research

Contact: Karen Teber
km463@georgetown.edu
Georgetown University Medical Center

Public Release: 16-Apr-2015
Bioinformatics
Novel online bioinformatics tool significantly reduces time of multiple genome analysis
A UK research collaboration developed a new bioinformatics pipeline that enables automated primer design for multiple genome species, significantly reducing turnaround time.

Contact: Hayley London
hayley.london@tgac.ac.uk
44-160-345-0107
The Genome Analysis Centre

Public Release: 16-Apr-2015
Molecular Systems Biology
Systems-wide genetic study of blood pressure regulation in the Framingham Heart Study
A genetic investigation of individuals in the Framingham Heart Study may prove useful to identify novel targets for the prevention or treatment of high blood pressure. The study, which takes a close look at networks of blood pressure-related genes, is published in the journal Molecular Systems Biology.

Contact: Barry Whyte
barry.whyte@embo.org
EMBO

Public Release: 15-Apr-2015
International Journal of Epidemiology
Paternal sperm may hold clues to autism
In a small study, Johns Hopkins researchers found that DNA from the sperm of men whose children had early signs of autism shows distinct patterns of regulatory tags that could contribute to the condition.
NIH/National Institute of Environmental Health Sciences, Autism Speaks

Contact: Catherine Kolf
ckolf@jhmi.edu
443-287-2251
Johns Hopkins Medicine

Public Release: 15-Apr-2015
PLOS ONE
New method increases accuracy of ovarian cancer prognosis and diagnosis
University of Utah scientists have uncovered patterns of DNA anomalies that predict a woman's outcome significantly better than tumor stage. In addition, these patterns are the first known indicator of how well a woman will respond to platinum therapy. Published in the journal PLOS ONE, the patterns were discovered by using a new mathematical technique in the analysis of DNA profiles from the Cancer Genome Atlas, a national database containing data from hundreds of ovarian cancer patients.
Utah Science, Technology, and Research Initiative, NIH/National Human Genome Research Institute, National Science Foundation

Contact: Julie Kiefer
jkiefer@neuro.utah.edu
801-597-4258
University of Utah Health Sciences

Public Release: 14-Apr-2015
Nature Scientific Data
New ORNL, NC State and LanzaTech DNA dataset is potent, accessible tool
Scientists focused on producing biofuels more efficiently have a new powerful dataset to help them study the DNA of microbes that fuel bioconversion and other processes.

Contact: Ron Walli
wallira@ornl.gov
865-576-0226
DOE/Oak Ridge National Laboratory

Public Release: 14-Apr-2015
The Journal of Alternative and Complementary Medicine
Antimalarial tea -- from herbal remedy to licensed phytomedicine
Malaria is a critical health problem in West Africa, where traditional medicine is commonly used alongside modern healthcare practices. An herbal remedy derived from the roots of a weed, which was traditionally used to alleviate malarial symptoms, was combined with leaves and aerial portions from two other plants with antimalarial activity, formulated as a tea, and eventually licensed and sold as an antimalarial phytomedicine.

Contact: Kathryn Ryan
kryan@liebertpub.com
914-740-2100
Mary Ann Liebert, Inc./Genetic Engineering News

Public Release: 14-Apr-2015
The Astrophysical Journal
Search for advanced civilizations beyond Earth finds nothing obvious in 100,000 galaxies
After searching 100,000 galaxies for signs of highly advanced life, a team of scientists using observations from NASA's WISE satellite has found no evidence of advanced civilizations there. The idea behind the research is that, if an entire galaxy had been colonized by an advanced spacefaring civilization, the energy produced by that civilization's technologies would be detectable in mid-infrared wavelengths. The research team's first paper about its results will be published on April 15, 2015.
John Templeton Foundation

Contact: Barbara K. Kennedy
science@psu.edu
814-863-4682
Penn State

Public Release: 14-Apr-2015
Molecular Biology and Evolution
Most comprehensive study to date reveals evolutionary history of citrus
Citrus fruits -- delectable oranges, lemons, limes, kumquats and grapefruits -- are among the most important commercially cultivated fruit trees in the world, yet little is known of the origin of the citrus species and the history of its domestication. Now, Jaoquin Dopazo et al., have performed the largest and most detailed genomic analysis on 30 species of citrus, representing 34 citrus genotypes, and used chloroplast genomic data to reconstruct its evolutionary history.

Contact: Joe Caspermeyer
MBEpress@gmail.com
480-258-8972
Molecular Biology and Evolution (Oxford University Press)

Public Release: 13-Apr-2015
Proceedings of the National Academy of Sciences
X-ray ptychography, fluorescence microscopy combo sheds new light on trace elements
Scientists have developed a new approach that combines ptychographic X-ray imaging and fluorescence microscopy to study the important role trace elements play in biological functions on hydrated cells.
National Institutes of Health, US Department of Energy, National Center for Research Resources

Contact: Tona Kunz
tkunz@anl.gov
630-252-5560
DOE/Argonne National Laboratory

Public Release: 10-Apr-2015
AZ Business magazine picks TGen's Dr. Daniel D. Von Hoff as 2015 Researcher of the Year
AZ Business magazine has named Dr. Daniel D. Von Hoff of the Translational Genomics Research Institute (TGen) as its 2015 Researcher of the Year. Dr. Von Hoff, M.D., TGen's Distinguished Professor and Physician-In-Chief, directs clinical trials at the Virginia G. Piper Cancer Center Clinical Trials at HonorHealth that translates TGen research discoveries into new treatments for patients.

Contact: Steve Yozwiak
syozwiak@tgen.org
602-343-8704
The Translational Genomics Research Institute

Public Release: 9-Apr-2015
Editing HIV out of our genome with CRISPR
In an attempt to render latent HIV completely harmless, researchers at the University of Massachusetts Medical School are using Cas9/CRISPR, a powerful gene editing tool, to develop a novel technology that can potentially cut the DNA of the latent virus out of an infected cell.
NIH/National Institute of Allergy and Infectious Diseases

Contact: Jim Fessenden
james.fessenden@umassmed.edu
508-856-2688
University of Massachusetts Medical School

Public Release: 9-Apr-2015
Molecular Genetics & Genomic Medicine
TGen finds likely genetic source of muscle weakness in 6 previously undiagnosed children
TGen scientists, using state-of-the-art genetic technology, have discovered the likely cause of a child's rare type of severe muscle weakness. The child was one of six cases in which TGen sequenced -- or decoded -- the genes of patients with Neuromuscular Disease and was then able to identify the genetic source, or likely genetic source, of each child's symptoms, according to a study published April 8 in the journal Molecular Genetics & Genomic Medicine.
Muscular Dystrophy Association, Flinn Foundation, Helios Education Foundation, Freeport-McMoRan Copper & Gold Foundation, and Arizona Biomedical Research Commission

Contact: Steve Yozwiak
syozwiak@tgen.org
602-343-8704
The Translational Genomics Research Institute

Public Release: 9-Apr-2015
NSF brings together UT Dallas computer scientists, industry for new tech hub
UT Dallas computer scientists hope that funding from the National Science Foundation to create an Industry/University Cooperative Research Center will help the Dallas area become a research hub for technology that enhances human abilities.
National Science Foundation

Contact: LaKisha Ladson
lakisha.ladson@UTDallas.edu
972-883-4183
University of Texas at Dallas

Public Release: 9-Apr-2015
Nature Communications
Epigenomic changes play an important role during the progression of melanoma
KU Leuven researchers have zeroed in on what makes cancer cells in melanoma so aggressive. They also succeeded in taming the effect in cell cultures. Melanoma, a type of skin cancer, is notoriously quick to metastasize and responds poorly to existing cancer treatments. In their study, published in Nature Communications, the researchers report a significant step forward in the characterization and potential treatment of melanoma.

Contact: Katrien Bollen
news@kuleuven.be
KU Leuven

Public Release: 8-Apr-2015
Nature
Improved understanding of protein complex offers insight into DNA replication initiation mechanism basics
A clearer understanding of the origin recognition complex -- a protein complex that directs DNA replication -- through its crystal structure offers new insight into fundamental mechanisms of DNA replication initiation. This will also provide insight into how ORC may be compromised in a subset of patients with Meier-Gorlin syndrome, a form of dwarfism in humans.
National Institutes of Health, US Department of Energy

Contact: Tona Kunz
tkunz@anl.gov
630-252-5560
DOE/Argonne National Laboratory

Public Release: 8-Apr-2015
Genetics
Hidden burden: Most people carry recessive disease mutations
Humans carry an average of one to two mutations per person that can cause severe genetic disorders or prenatal death when two copies of the same mutation are inherited, according to estimates published today in the journal Genetics. The new numbers were made possible by a long-term collaboration between medical researchers and a unique community that has maintained detailed family histories for many generations.

Contact: Cristy Gelling
press@genetics-gsa.org
412-478-3537
Genetics Society of America

Public Release: 8-Apr-2015
Journal of the National Cancer Institute
Genetic screening could improve breast cancer prevention
A test for a wide range of genetic risk factors could improve doctors' ability to work out which women are at increased risk of developing breast cancer, a major study of more than 65,000 women has shown. Improving the accuracy of risk analysis using genetic screening could guide breast cancer prevention in several ways -- for instance by offering high-risk women increased monitoring, personalized advice and preventative therapies.
Cancer Research UK, European Union, Breakthrough Breast Cancer, National Institutes of Health

Contact: Henry French
henry.french@icr.ac.uk
020-715-35582
Institute of Cancer Research

Public Release: 7-Apr-2015
Human Genome Variation
A better biomarker to predict cetuximab response in CRC patients
Scientists at Insilico Medicine Inc. and Champions Oncology Inc. have successfully demonstrated a method to predict response to cetuximab in patients with colorectal cancer using OncoFinder pathway activation strength. The study identified a novel prognostic marker in colorectal cancer treated with cetuximab.

Contact: Qingsong Zhu
zhu@insilicomedicine.com
410-710-9674
InSilico Medicine, Inc.

Public Release: 7-Apr-2015
Seena Magowitz Foundation funds TGen's zebrafish studies of pancreatic cancer
Today, scientists at the Translational Genomics Research Institute (TGen) are using zebrafish to accelerate investigations of pancreatic cancer, the nation's fourth-leading cause of cancer-related death. The studies are funded by the Scottsdale, Arizona-based Seena Magowitz Foundation. The amount of the funding was not disclosed.
Seena Magowitz Foundation

Contact: Steve Yozwiak
syozwiak@tgen.org
602-343-8704
The Translational Genomics Research Institute

Public Release: 6-Apr-2015
ROIS collaboration on Data Centric Science
ROIS based in Tokyo signed MoUs on Data Centric Science research collaboration with European organizations, CSC -- IT Center for Science, Finland, DSI and EUDAT. The MoUs were signed on Feb. 25-26 in Tokyo, and are expected to form the basis of further collaboration between the parties.
Research Organization of Information and Systems

Contact: Ms. Rue Ikeya
ikeya@rois.ac.jp
81-364-026-226
Research Organization of Information and Systems

Public Release: 6-Apr-2015
Cancer Biotherapy and Radiopharmaceuticals
Can cancer vaccines prolong survival?
Therapeutic anti-cancer vaccines developed to treat metastatic disease such as advanced prostate cancer or melanoma rarely have a noticeable effect on the tumor but have been associated with a statistically significant increase in patient survival. Robert O. Dillman, M.D., NeoStem Inc., asserts that 'overall survival' rather than 'progression-free survival' should be the gold standard for evaluating the efficacy of cancer vaccines in clinical trials, in a provocative new article published in Cancer Biotherapy and Radiopharmaceuticals.

Contact: Kathryn Ryan
kryan@liebertpub.com
914-740-2100
Mary Ann Liebert, Inc./Genetic Engineering News

Public Release: 2-Apr-2015
Journal of Applied Ecology
Bridging the gap between biodiversity data and policy reporting needs
Reporting under policy instruments to inform on the trends in biodiversity requires information from a range of different elements of biodiversity, from genetically viable populations to the structure of ecosystems. A new research funded by the EU FP7 project EU BON looks into the Essential Biodiversity Variables as an analytic framework to identify ways in which gaps between biodiversity data and policy reporting needs could be bridged.

Contact: Dr. Ilse Geijzendorffer
ilse.geijzendorffer@imbe.fr
Pensoft Publishers

Showing releases 101-125 out of 793.

<< < 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 > >>